These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 28910610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
    Song X, Qi J, Li X, Zhou M, He J, Chu T, Han Y.
    Platelets; 2023 Dec; 34(1):2229905. PubMed ID: 37409458
    [Abstract] [Full Text] [Related]

  • 4. Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid Leukemia.
    Ma R, Ma Y, Cui Q, Wu D, Tang X.
    Clin Appl Thromb Hemost; 2024 Dec; 30():10760296241278345. PubMed ID: 39370845
    [Abstract] [Full Text] [Related]

  • 5. Avatrombopag for the salvage treatment of platelet transfusion refractoriness.
    Qin Y, Wang Y, Zhang Y, Jiao Y, Ye J.
    Ther Adv Hematol; 2024 Dec; 15():20406207241237606. PubMed ID: 38481948
    [Abstract] [Full Text] [Related]

  • 6. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA, Choo SY, Little JA.
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [Abstract] [Full Text] [Related]

  • 7. Severe Platelet Transfusion Refractoriness in Association with Antibodies Against CD36.
    Schmidt AE, Sahai T, Refaai MA, Sullivan M, Curtis BR.
    Lab Med; 2020 Sep 01; 51(5):540-544. PubMed ID: 31925433
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness.
    Beligaswatte A, Tsiopelas E, Humphreys I, Bennett G, Robinson K, Davis K, Bardy P.
    Br J Haematol; 2013 Aug 01; 162(3):409-12. PubMed ID: 23651440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, Mahlknecht U, Ho A, Schaich M, Kramer M, Kaufmann M, Leimer L, Schwerdtfeger R, Conradi R, Dölken G, Klenner A, Hänel M, Herbst R, Junghanss C, Ehninger G, Study Alliance Leukemia.
    Lancet; 2012 Oct 13; 380(9850):1309-16. PubMed ID: 22877506
    [Abstract] [Full Text] [Related]

  • 12. Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness.
    Chellaiya GK, Nair CK, Raghavan V, Pandian RJ, Vinod R, Murugesan M.
    Asian J Transfus Sci; 2021 Oct 13; 15(1):90-93. PubMed ID: 34349464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE, Othus M, Powell MA, Gardner KM, Rizzuto DL, Hendrie PC, Becker PS, Pottinger PS, Estey EH, Walter RB.
    JAMA Oncol; 2015 Nov 13; 1(8):1120-7. PubMed ID: 26355382
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.
    Oka S, Muroi K, Mori M, Matsuyama T, Fujiwara S, Oh I, Ono Y, Kikuchi S, Sato K, Ueda M, Toshima M, Ozaki K, Takatoku M, Nagai T, Ozawa K.
    Intern Med; 2007 Nov 13; 46(19):1669-70. PubMed ID: 17917331
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Refractoriness to platelet transfusions in children with acute leukemia.
    DeCoteau J, Haddad S, Blanchette V, Poon A.
    J Pediatr Hematol Oncol; 1995 Nov 13; 17(4):306-10. PubMed ID: 7583385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.